Clinical Trial Update: Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL） [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating IFN-α combined with CAR-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CAR-T cell therapy
• IFN-α (interferon-alpha)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN